Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Emeis's pretax income for the
six
months ended in Jun. 2026 was $-31 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Jun. 2026 was $-180 Mil.
Emeis's pretax margin was -0.90%.
During the past 13 years, Emeis's highest Pretax Margin was 26.94%. The lowest was -98.07%. And the median was 4.89%.
During the past 13 years, Emeis's highest Pretax Margin was 26.94%. The lowest was -98.07%. And the median was 4.89%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emeis Pre-Tax Income Related Terms
Emeis Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Emeis's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Emeis's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emeis Pre-Tax Income vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Emeis's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Emeis's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-180 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emeis (ORPEF) has a Pre-Tax Income of $-180 Mil as of Jun. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Emeis and its competitors.
Is Emeis' Pre-Tax Income too high?
Emeis' current Pre-Tax Income is $-180 Mil. Overall, Emeis has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Emeis' Pre-Tax Income compare to HCA and THC?
Emeis' Pre-Tax Income of $-180 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Healthcare Providers & Services company?
A good Pre-Tax Income depends on the Healthcare Providers & Services industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Emeis and its competitors. Emeis's current Pre-Tax Income is $-180 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emeis stock overvalued right now?
Emeis (ORPEF) has a current Pre-Tax Income of $-180 Mil. The stock's GF Value™ is $12.98, compared to a current price of $14.22 — trading 9.6% above its estimated fair value. The current Pre-Tax Income is $-180 Mil. Emeis' overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Emeis (ORPEF), the current Pre-Tax Income is $-180 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Emeis (ORPEF) Overvalued in 2026?
Based on GuruFocus' analysis, Emeis stock appears to be overvalued.
The current stock price of $14.22 is trading 9.6% above its estimated GF Value™ of $12.98.
Key valuation signals for ORPEF:
Pre-Tax Income: $-180 Mil
GF Value™: $12.98 vs. price of $14.22 (9.6% above fair value)
No single metric tells the full story. See the ORPEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Emeis operates a comprehensive care offering of mental health clinics and medical and rehabilitation care, retirement homes, assisted living and home care.
60GF Score
Get the complete analysis for ORPEF
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORPEF has been successfully added to your 
